Palogic Value Management’s Amgen AMGN Stock Holding History

Palogic Value Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.73M	Buy	7,773 +6	+0.1%	+$2.14K	1.16%	21
2025 Q4	$2.54M	Buy	7,767 +103	+1%	+$32.7K	1.06%	25
2025 Q3	$2.16M	Buy	7,664 +132	+2%	+$38.3K	0.87%	28
2025 Q2	$2.1M	Sell	7,532 -16	-0.2%	-$4.53K	0.86%	33
2025 Q1	$2.35M	Buy	7,548 +369	+5%	+$109K	1.02%	32
2024 Q4	$1.87M	Sell	7,179 -24	-0.3%	-$7.12K	0.71%	45
2024 Q3	$2.32M	Buy	7,203 +47	+0.7%	+$15.4K	0.79%	32
2024 Q2	$2.24M	Buy	7,156 +67	+0.9%	+$19.7K	0.95%	30
2024 Q1	$2.02M	Buy	7,089 +90	+1%	+$26.3K	0.87%	36
2023 Q4	$2.02M	Buy	6,999 +119	+2%	+$32.4K	0.89%	38
2023 Q3	$1.85M	Buy	6,880 +35	+0.5%	+$8.73K	0.88%	38
2023 Q2	$1.52M	Sell	6,845 -45	-0.7%	-$10.4K	0.71%	48
2023 Q1	$1.67M	Buy	6,890 +107	+2%	+$26.3K	0.82%	45
2022 Q4	$1.78M	Buy	+6,783	New	+$1.82M	0.93%	37

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Palogic Value Management's AMGN Position: Q1 2026 in Review

Palogic Value Management increased its Amgen (AMGN) stake by 0.08% in Q1 2026, buying an estimated $2.14K and bringing the position to 7,773 shares worth $2.73M. The position accounts for 1.16% of the portfolio, ranked #21.

Palogic Value Management first reported a position in AMGN in Q4 2022 and has held it in 14 quarters since. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Palogic Value Management held 7,773 shares of Amgen worth $2.73M as of Q1 2026.
Palogic Value Management bought 6 Amgen shares in Q1 2026, an estimated $2.14K.
Amgen made up 1.16% of Palogic Value Management's portfolio in Q1 2026, its #21 holding.
Palogic Value Management first reported a position in Amgen in Q4 2022 and has held it in 14 quarters since.
3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Palogic Value Management's 13F filing for Q1 2026, filed 15 May 2026.